Finance
Straumann H1 earnings miss market expectations
Published by Global Banking and Finance Review
Posted on August 13, 2025
1 min readLast updated: January 22, 2026
Global Banking and Finance Review
Company
Published by Global Banking and Finance Review
Posted on August 13, 2025
1 min readLast updated: January 22, 2026
Straumann's H1 earnings missed expectations with EBIT at 358 million francs. Despite macroeconomic challenges, sales grew to 1.35 billion francs.
(Reuters) -Swiss dental implant maker Straumann on Wednesday reported first half earnings which were below market expectations and warned macroeconomic uncertainties were expected to persist.
The company, which specialises in tooth replacement and orthodontic solutions, reported core earnings before interest and taxes (EBIT) of 358 million francs in the first half, slightly below consensus estimates of 365 million francs.
Its sales grew to 1.35 billion Swiss francs ($1.67 billion)in the period, broadly in line with analysts' expectations of 1.36 billion francs in a Vara consensus.
Straumann confirmed its 2025 sales forecast, saying it aims to achieve organic revenue growth in the high single-digit percentage range.
The company said while macroeconomic uncertainties, including rising trade tariffs and regional demand fluctuations are expected to persist, its "strong fundamentals" provided resilience.
Straumann has shown resilience to changing U.S. tariff policies as 80% of the products it sells in the United States are manufactured domestically.
($1 = 0.8063 Swiss francs)
(Reporting by Cian Muenster and Bartosz Dabrowski in Gdansk)
Straumann reported core earnings before interest and taxes (EBIT) of 358 million francs in the first half, slightly below market expectations.
The company's sales grew to 1.35 billion Swiss francs, which was broadly in line with analysts' expectations of 1.36 billion francs.
Straumann confirmed its 2025 sales forecast, aiming for organic revenue growth in the high single-digit percentage range.
The company warned that macroeconomic uncertainties, including rising trade tariffs and regional demand fluctuations, are expected to persist.
Straumann has shown resilience to changing U.S. tariff policies, as 80% of the products it sells in the United States are manufactured domestically.
Explore more articles in the Finance category
